Technologically advanced medical devices are driving the growth of United States Patient At Home Testing Kits Market, in the forecast period.
According to TechSci report on, “United States Patient At Home Testing Kits Market By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, COVID-19 Testing, Urine analysis, Others) By Sample (Blood, Urine, Saliva, Swab, Others) By Usage (Reusable v/s Disposable) By Distribution Channel (Retail Stores, Hypermarket/Supermarket, E-Commerce) By Region, Competition Forecast & Opportunities, 2026”, United States patient at home testing kits market is anticipated to project a robust growth with an impressive CAGR in the forecast period, 2022-2026. The market attributes include the popularity of the medical devices that are employed to manage and monitor a consumer’s health like measuring blood pressure, blood glucose level, blood oxygen levels etc. with use of minor technologically advanced devices. With the growing concerns among the population of the country the market for patient at home testing kits in the United States is multiplying in the upcoming five years. Moreover, the rising number of the health conscious consumers is driving the growth of the market in the next five years. Also, demand of the patients for medical devices that can help them keep a check on their vitals at the comfort of their homes along with the technical advancement that manages and records the daily vitals is also anticipating the growth of the United States patient at home testing kits market in the next five years. Marketed as more confidential, cost-effective, and less time-consuming, home diagnostic kits now come with cutting-edge technology such as Artificial Intelligence (AI) and Internet of Things (IoT) these devices are experiencing the surge in the demand.
In the recent wake of COVID -19 outbreak the number of concerned patients have increased. The infectious disease is said to affect the patient with compromised or weakened immune system. The patients already suffering from high or low blood pressure, diabetes and othe chronic disease were trying to keep a check and monitor their conditions to avoid being contaminated with the infection. Hus, the sale of these medical devices increased many folds. Although the market and economy of the country suffered the healthcare sector had the burdened responsibility of finding the preventive measures and vaccines for the disease and to minimize the infection the world observed a lockdown that affected the economy further although the sale of oximeters, blood glucose monitors and blood pressure monitors increased any folds and thereby supported the growth of the United States patient at home testing kits market.
Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on “United States Patient At Home Testing Kits Market”
The US patient at home testing kits market is segmented by test type, sample, usage, distribution channel, competitional landscape, and regional distribution. Based on sample, the market was further bifurcated into blood, urine, saliva, swab, and others. O conduct any kind of health checkup; some samples are collected from the patient. Most of the time the sample collected in the blood due to the presence of the plasma in the blood that carries almost all the component traces required for the testing. Due to this advantage, blood samples dominate the market segment too. To analyze blood glucose level also, a small sample of blood is required. Blood testing holds the majority of the testing carried out. Urine sample are collected for the tests involving urine analysis, or to check the liver, pancreas, and kidney functionality as well as to find any infections in the urinary tract. The recent outbreak of COVID-9 has rapidly grown the demand of swab test and saliva tests for the identification of the coronavirus infected patients.
Market players like Lucira Health Inc., Essenlix Corporation, Abbott Laboratories, Inc., Roche Diagnostics Corporation, Siemens Medical Solutions USA, Inc., Thermo Fischer Scientific, Inc., Scanwell Health, Inc., Quidel Corporation, GE Healthcare, ACON Laboratories, Inc., among others hold the large shares of the US patient at home testing kits market. These market players are actively involved in the research and development to bring the technologically advanced medical devices for the satisfaction of the consumer demands. Moreover, these devices have proven to be of help for the doctors and the experts in keeping regular tabs over their chronic patients over the time while the patient can take home care at affordable rates and keep their health in check. Other strategic recommendations include partnerships and acquisitions among the market players, and the distributors.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7556
Customers can also request for 10% free customization on this report.
“Patient with the chronic diseases and in the need of home care setting are the major consumers of the patient at home testing kits. Along with them, health conscious consumers with demand of regular monitoring devices are responsible for the growth of the US patient at home testing kits market in the next five years. Market players must indulge in the technological advance medical devices that satisfies the consumer demand. Smart phones accessible applications that record and stores the patient data for the future consultations will support the growth of the market as well as the market player’s position in the market,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Patient At Home Testing Kits Market By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, COVID-19 Testing, Urine analysis, Others) By Sample (Blood, Urine, Saliva, Swab, Others) By Usage (Reusable v/s Disposable) By Distribution Channel (Retail Stores, Hypermarket/Supermarket, E-Commerce) By Region, Competition Forecast & Opportunities, 2026” has evaluated the future growth potential of United States patient at home testing kits market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in US patient at home testing kits market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017